(PresidentialInsider.com)- Next Monday, pharmaceutical companies and drug distributors will attend a summit at the White House to discuss the distribution of the COVID-19 vaccine. It comes as two vaccines developed by American companies inch closer towards emergency use approval by the Food and Drug Administration, with the first vaccines expected to start rolling out next week.
It’s the latest success for President Donald Trump’s Operation Warp Speed, which reduced regulatory barriers and invested billions of dollars to help American pharmaceutical companies develop a vaccine in a record-setting time.
With the vaccine expected to begin rolling out next week, the country faces a huge uphill challenge to distribute it. The vaccine must be stored in sub-freezing temperatures, meaning specialist vehicles and equipment will be required to ensure that vaccine remains viable throughout its journey from laboratories to distribution and vaccination centers.
White House Press Secretary Kayleigh McEnany described the vaccine as the “Trump vaccine” during a press briefing on Wednesday.
“It’s the Trump vaccine” pic.twitter.com/MTFff7sQfk
— Aaron Rupar (@atrupar) December 2, 2020
She explained how the federal government aims to distribute 40 million doses by the end of the year, and said having a businessman as president had paid off.
Representatives of the two companies that have developed COVID-19 vaccines that are more than 90% effective, Moderna and Pfizer, will be among those attending the summit on Monday. They will be joined by representatives from an umber of distribution companies that will be providing the vehicles and logistics to distribute the vaccine across the country.
The FDA is expected to review the emergency use authorization for the Pfizer vaccine on December 10, with the vaccine being made available before the end of the week once it gets approval. As part of Operation Warp Speed, several logistical steps are happening at the same time, meaning distribution plans are already underway, in anticipation of the FDA approving the drug.
The United Kingdom has already approved the Pfizer officering and is expected to be rolling out vaccines early next week, indicating that the United States is likely to follow suit.
— Boris Johnson (@BorisJohnson) December 2, 2020
The White House summit is about “setting the stage,” a Pfizer representative told the press.
“There’s a thought process that distribution could begin 24 hours after the FDA reviews and approves the emergency use approval application from Pfizer, meaning Dec. 11 or Dec. 12 if delayed.”
Could we be nearing the end of this pandemic?